Literature DB >> 30858610

Respiratory management during therapeutic hypothermia for hypoxic-ischemic encephalopathy.

Eniko Szakmar1,2, Agnes Jermendy1, Mohamed El-Dib3.   

Abstract

Therapeutic hypothermia (TH) has become the standard of care treatment to improve morbidity and mortality in infants with hypoxic-ischemic encephalopathy (HIE). Although TH has clearly proven to be beneficial, recent studies suggest optimization of respiratory management as an approach to prevent further damage and improve neurodevelopmental outcome. The ventilatory management of asphyxiated neonates presents a challenge because both the hypoxic insult and TH have an impact on respiratory functions. Although the danger of recurrence of hypocapnia is well recognized, a brief period of severe hyperoxia also can be detrimental to the previously compromised brain and have been shown to increase the risk of adverse neurodevelopmental outcomes. Therefore, judicious ventilatory management with rigorous monitoring is of particular importance in patients with HIE. In the present review, we provide an overview of the currently available evidence on pulmonary function, respiratory morbidities, and ventilation strategies in HIE and we highlight possible future research directions.

Entities:  

Mesh:

Year:  2019        PMID: 30858610     DOI: 10.1038/s41372-019-0349-2

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  2 in total

1.  Mechanical Ventilation, Partial Pressure of Carbon Dioxide, Increased Fraction of Inspired Oxygen and the Increased Risk for Adverse Short-Term Outcomes in Cooled Asphyxiated Newborns.

Authors:  Stamatios Giannakis; Maria Ruhfus; Mona Markus; Anja Stein; Thomas Hoehn; Ursula Felderhoff-Mueser; Hemmen Sabir
Journal:  Children (Basel)       Date:  2021-05-21

2.  Morphine and fentanyl exposure during therapeutic hypothermia does not impair neurodevelopment.

Authors:  Julia K Gundersen; Ela Chakkarapani; Sally Jary; David A Menassa; Emma Scull-Brown; Adam Frymoyer; Lars Walløe; Marianne Thoresen
Journal:  EClinicalMedicine       Date:  2021-06-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.